Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
06/12/2003 | US20030109063 Automated crystallizationexperiment setup apparatus comprising sensor |
06/12/2003 | US20030109046 Multiwell plate adapted for automated crystallization |
06/12/2003 | US20030108907 Nucleic acids, proteins, and antibodies |
06/12/2003 | US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation |
06/12/2003 | US20030108572 Antigenic preparations and the isolation of such preparations |
06/12/2003 | US20030106798 Factor VIII separation |
06/11/2003 | EP1318195A1 A structure for presenting desired peptide sequences |
06/11/2003 | EP1318142A1 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them |
06/11/2003 | EP1317475A2 Peptides for use in culture media |
06/11/2003 | EP1114060B1 Process for producing peptides from biological fluids and peptides obtainable by said process |
06/11/2003 | EP0779894B1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
06/11/2003 | CN1422867A Method for extracting and separating haematoglobin from animal blood |
06/10/2003 | US6576609 Methods and compositions for generating angiostatin |
06/10/2003 | US6576454 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme |
06/10/2003 | US6576424 Solid support for use in the determination, classification and mapping of biopolymer sequences |
06/10/2003 | CA2234208C Influenza vaccine |
06/10/2003 | CA2143416C Inhibitor of collagen-stimulated platelet aggregation |
06/10/2003 | CA2121121C Preparation of recombinant borrelia proteins |
06/10/2003 | CA2076652C Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase |
06/10/2003 | CA2065553C Stabilized factor viii preparations |
06/10/2003 | CA2065323C Isolation and purification of lung surfactant protein |
06/10/2003 | CA2055670C Retroviral protease inhibiting compounds |
06/05/2003 | WO2003046150A2 Glycoprotein remodeling using endoglycanases |
06/05/2003 | WO2003046137A2 Hiv envelope v3-ccr5 binding site immunogen |
06/05/2003 | WO2003045980A2 Glycopeptide remodeling using amidases |
06/05/2003 | WO2003045975A2 Solid-phase immobilization of proteins and peptides |
06/05/2003 | WO2003045546A1 The use of metal-chelating adsorbents |
06/05/2003 | WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof |
06/05/2003 | WO2002098902A3 Improved native chemical ligation with three or more components |
06/05/2003 | WO2002046230A3 G-protein coupled receptors |
06/05/2003 | WO2002042330A3 Cystoskeleton-associated proteins |
06/05/2003 | US20030106097 Hydrolases; insect/disease resistant plants; controlling cellulose concentration during cell wall deposition |
06/05/2003 | US20030105327 By-product inhibition of the diketopiperazine derivative by carrying out in aqueous liquid a series of operations under given conditions in the same solvent; making enalapril maleate for example |
06/05/2003 | US20030105293 Human circulating cytokine cc-1 |
06/05/2003 | US20030105243 Process for preparing tritylated polystylene resin |
06/05/2003 | US20030105224 Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
06/05/2003 | US20030105000 Methods and compositions for inhibiting GRB7 |
06/05/2003 | US20030104571 Flexible method and apparatus for high throughput production and purification of multiple proteins |
06/05/2003 | US20030104557 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; cancer diagnosis |
06/05/2003 | US20030104556 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104555 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104554 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypetide; cancer diagnosis |
06/05/2003 | US20030104553 Isolation of human chorionic gonadotropin protein through ion exchange and size exclusion chromatography |
06/05/2003 | US20030104550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104549 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104545 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104544 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
06/05/2003 | US20030104526 Rational design of polypeptides containing non-modulatory zinc finger, i.e, its sequence specificity depends on its location in multi-finger protein |
06/05/2003 | US20030104516 Protein kinase npk-110 |
06/05/2003 | US20030104509 Kit for use in digestion and separation of polypeptide segments |
06/05/2003 | US20030104411 Microarray for use in analysis and classification of biological samples |
06/05/2003 | US20030104384 Trangenic cell library for monitoring phenotypic adjustments associated with gene transfer |
06/05/2003 | US20030104360 Synthetic receptors, libraries and uses thereof |
06/05/2003 | US20030103936 Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides |
06/05/2003 | CA2468230A1 Glycopeptide remodeling using amidases |
06/04/2003 | EP1316562A2 Composition comprising a covalent polyethylene glycol (PEG)-protein adduct |
06/04/2003 | EP1315965A2 Methods and compositions for in vitro targeting |
06/04/2003 | EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
06/04/2003 | EP1315830A2 Compositions and methods for targeting peptides in humans in vivo |
06/04/2003 | EP1315826A1 Enhanced in vitro synthesis of active proteins containing disulfide bonds |
06/04/2003 | EP1315756A2 Electroprocessed fibrin-based matrices and tissues |
06/04/2003 | EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
06/04/2003 | EP1315740A1 Method for purifying recombinant proteins expressed as insoluble aggregates |
06/04/2003 | EP1315739A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
06/04/2003 | EP1315738A1 Extended native chemical ligation |
06/04/2003 | EP1315699A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
06/04/2003 | EP1315513A2 "pseudo"-native chemical ligation |
06/04/2003 | EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
06/04/2003 | EP1315511A2 Synthetic erythropoiesis stimulating proteins |
06/04/2003 | EP1185624A4 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
06/04/2003 | EP1151299A4 Method of site specific labeling of proteins and uses therefor |
06/04/2003 | EP0862581B1 Heparin chromatography of erythropoietins |
06/04/2003 | EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
06/04/2003 | CN1421458A Prepn of fat-free hematoglobin |
06/03/2003 | US6573409 Prepared from 3,3-dimethylbutanol. Intermediate 3,3-dimethylbutanol is obtained by reacting ethylene, isopropylene and sulfuric acid to produce a 3,3- dimethylbutyl ester which is hydrolyzed to the alcohol. |
06/03/2003 | US6573363 Isolated polypeptide of given amino acid sequence; may be useful in the treatment of diseases characterized by overexpression of glycoprotein hormone; can use in diagnosis, treatment or prevention of cancer and diabetes |
06/03/2003 | US6573110 Dual processing of different molecules coated on a library of beads; used in drug screening; faster |
06/03/2003 | US6573056 Process for purifying factor VII and activated factor VII |
06/03/2003 | US6572767 Simulated activity of Protein A displayed by ligands attached to a cellulose bead surface |
06/03/2003 | CA2185574C Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry |
06/03/2003 | CA2076424C Phosphoinositol-glycan-peptide with insulin-like action |
05/30/2003 | WO2003044515A1 Analysing spots in a 2-d array |
05/30/2003 | WO2003044485A2 Proteonomic methods for diagnosis and monitoring of breast cancer |
05/30/2003 | WO2003044055A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
05/30/2003 | WO2003044052A1 Antifreeze proteins originating in fishes |
05/30/2003 | WO2003044045A2 Peptides promoting cell adherence, growth and secretion |
05/30/2003 | WO2003044043A1 Method of protein purification |
05/30/2003 | WO2003044042A1 Site selective acylation |
05/30/2003 | WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
05/30/2003 | WO2003025565A3 Preparation of highly-purified plasma membranes |
05/30/2003 | WO2003008088A3 Method and assembly for attaching substances that have been immobilised in transport agents and monomer particles |
05/30/2003 | WO2002072621A3 Cyclohexapeptide having antimicrobial activity |
05/30/2003 | WO2002033065A3 Method for producing proteins by electroporation |
05/30/2003 | WO2001087922A3 Derivatisation of proteins in aqueous solution |
05/30/2003 | CA2467181A1 Peptides promoting cell adherence, growth and secretion |
05/30/2003 | CA2467048A1 Method of protein purification |
05/29/2003 | US20030100739 Generation of polysaccharide-protein biopolymer; prepare polysaccharide solution, adjust hydrogen ion concentration, expose to cross linking agent, recover biopolymer |
05/29/2003 | US20030100561 Treatment of insulin resistance with growth hormone secretagogues |
05/29/2003 | US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders |
05/29/2003 | US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |